MiR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

BMC Urology

Volumn 12, Issue , 2012, Pages

  Reis, Sabrina Thalita ^a   Pontes Junior, José ^a,b   Antunes, Alberto Azoubel ^a,b   Dall'Oglio, Marcos Francisco ^a   Dip, Nelson ^a   Passerotti, Carlo Camargo ^a,b   Rossini, Guilherme Ayres ^b   Morais, Denis Reis ^a   Nesrallah, Adriano Joao ^a   Piantino, Camila ^a   Srougi, Miguel ^a   Leite, Katia R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Nove de Julho University   (Brazil)

Author keywords

Metaloproteinases; Micro RNA; Prognosis; Prostate cancer; RECK

Indexed keywords

GELATINASE B; MICRORNA 21; PROSTATE SPECIFIC ANTIGEN; REGULATOR PROTEIN; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIF; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; GENETIC TRANSFECTION; GLEASON SCORE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULARLY TARGETED THERAPY; OUTCOME ASSESSMENT; PROSTATE CANCER; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861474291     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-12-14     Document Type: Article

References (23)

1. Cancer statistics, 2011. Jemal A, Siegel R, Ward E, Brawley O, CA Cancer J Clin 2011 61 212 236 10.3322/caac.20121 21685461
2. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens. Berger AP, Spranger R, Kofler K, Steiner H, Bartsch G, Horninger W, Prostate 2003 57 93 98 10.1002/pros.10278 12949932 (Pubitemid 37204489)
3. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Peek RM, Blaser MJ, Nat Rev Cancer 2002 2 28 37 10.1038/nrc703 11902583 (Pubitemid 37328805)
4. MicroRNA function: multiple mechanisms for a tiny RNA? Pillai RS, RNA 2005 11 1753 1776 10.1261/rna.2248605 16314451 (Pubitemid 41720024)
5. Oncogenes and cancer. Croce CM, N Engl J Med 2008 358 502 511 10.1056/NEJMra072367 18234754 (Pubitemid 351185806)
6. microRNAs join the p53 network-another piece in the tumour-supression puzzle. He L, He X, Lowe SW, Hannon GJ, Nat Rev Cancer 2007 7 819 822 10.1038/nrc2232 17914404 (Pubitemid 350006254)
7. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Kent OA, Mendell JT, Onocogene 2006 25 6188 6196 10.1038/sj.onc. 1209913 (Pubitemid 44527849)
8. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H, Oncogene 2008 27 2128 2136 10.1038/sj.onc.1210856 17968323 (Pubitemid 351485639)
9. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Meng F, Henson R, Wehbe-Janek H, Gholshal K, Jacob ST, Patel T, Gastroenterology 2007 133 647 658 10.1053/j.gastro.2007.05.022 17681183 (Pubitemid 47187346)
10. miR-21-mediated tumor growth. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY, Oncogene 2007 26 2799 2803 10.1038/sj.onc.1210083 17072344 (Pubitemid 46663837)
11. MicroRNA-21 targets the tumor suppressor genes tropomyosin 1 (TPM1). Zhu S, Si ML, Wu H, Mo YY, J Biol Chem 2007 282 14328 14336 10.1074/jbc.M611393200 17363372 (Pubitemid 47100416)
12. Prognostic relevance of uPAR-del4/5and TIMP-3 mRNA expression levels in breast cancer. Kotzsch M, Farthmann J, Meye A, Fuessel S, Baretton G, Tjan-Heijnen VC, Schmitt M, Luther T, Sweep FC, Magdolen V, Span PN, Eur J Cancer 2005 41 2760 2768 10.1016/j.ejca.2005.09.002 16256342 (Pubitemid 41607570)
13. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F, Eur J Cancer 2004 10 1617 1623 (Pubitemid 38757753)
14. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM, Mol Cell Biol 2008 28 5369 5380 10.1128/MCB.00479-08 18591254
15. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu W, Yang K, He X, Chen S, J Hepatol 2010 53 98 107 10.1016/j.jhep.2010.02.021 20447717
16. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M, Proc Natl Acad Sci U S A 1998 95 13221 13226 10.1073/pnas.95.22.13221 9789069 (Pubitemid 28509552)
17. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Zhang Z, Li Z, Gao C, Lab Invest 2008 88 1358 1366 10.1038/labinvest.2008.94 18794849
18. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Chan JA, Krichevsky AM, Kosik KS, Cancer Res 2005 65 6029 6033 10.1158/0008-5472.CAN- 05-0137 16024602 (Pubitemid 40994386)
19. A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM, Procl. Natl. Acad. Sci. USA 2006 103 2257 2261 10.1073/pnas.0510565103 (Pubitemid 43271657)
20. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Zhu S, Wu H, Wu G, Nie D, Sheng S, Mo YY, Cell Res. 2008 18 350 359 10.1038/cr.2008.24 18270520 (Pubitemid 351333899)
21. The membrane anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Oh J, Takahashi R, Kondo S, Kawashima S, Kitayama H, Takahashi C, Noda M, Cell 2001 107 789 800 10.1016/S0092-8674(01)00597-9 11747814 (Pubitemid 34033671)
22. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. Chang CK, Hung WC, Chang HC, J Cell Mol Med 2008 12 2781 2789 10.1111/j.1582-4934.2008.00215.x 18194466
23. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Oh J, Takahashi R, Kondo S, Cell 2001 107 789 800 10.1016/S0092-8674(01)00597-9 11747814 (Pubitemid 34033671)